Kawasaki, Japan

Kozo Toyota

This inventor holds 3 USPTO granted patents. Top assignee: Ajinomoto Co., Ltd.. Active years: 1993-1995.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 1993-1995

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kozo Toyota: Innovator in Pharmaceutical Chemistry

Introduction

Kozo Toyota is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of piperidine derivatives. With a total of 3 patents to his name, his work has implications for the treatment of various medical conditions.

Latest Patents

One of his latest patents focuses on piperidine derivatives and hypotensives containing the same. This patent describes a piperidine compound characterized by a specific formula, where A represents a fused aromatic ring. The compound includes various substituents such as hydrogen, chloro, or methoxy, and features a range of structural possibilities for the components X, Y, and Q. These innovations are crucial for advancing therapeutic options in medicine.

Career Highlights

Kozo Toyota is associated with Ajinomoto Co., Ltd., a leading company in the food and pharmaceutical industries. His work at Ajinomoto has allowed him to explore and develop new chemical compounds that can lead to improved health outcomes. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the field.

Collaborations

Throughout his career, Kozo Toyota has collaborated with esteemed colleagues such as Chikahiko Eguchi and Hideki Domoto. These partnerships have fostered a collaborative environment that enhances innovation and research in pharmaceutical development.

Conclusion

Kozo Toyota's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the industry. His work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…